<html>
<head>PUBMED IDs for LIN-41</head>
<body bgcolor='#C5F0F2'><h1>LIN-41</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11822024/'>Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene.</a> February 1  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/18050425/'>C. elegans microRNAs.</a> December 1  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/23512656/'>LIN-41/TRIM71: emancipation of a miRNA target.</a> May 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24239284/'>The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes.</a> August 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24239247/'>An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.</a> February 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24239242/'>MicroRNA-150 inhibits expression of adiponectin receptor 2 and is a potential therapeutic target in patients with chronic heart failure.</a> November 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24239235/'>BRCA1 shields vascular smooth muscle cells from oxidative stress.</a> July 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25669883/'>The let-7 microRNA directs vulval development through a single target.</a> April 15  2015<br></body></html>
